Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    NeuroBo Pharmaceuticals I...

    NASDAQ: NRBO · Real-Time Price · USD
    2.36
    null (null%)
    At close: Nov 27, 2024, 10:00 PM

    NeuroBo Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a 7K 28K 72K
    Gross Profit
    		 n/a -7K -28K -72K
    Operating Income
    		 -28.81M -15.89M -19.63M -15.3M
    Interest Income
    		 920K 461K 2.19K 14K
    Pretax Income
    		 -27.59M -12.47M -13.97M -15.28M
    Net Income
    		 -27.59M -12.47M -13.97M -15.28M
    Selling & General & Admin
    		 7.26M 6.73M 8.64M 8.75M
    Research & Development
    		 21.55M 9.15M 2.75M 6.55M
    Other Expenses
    		 n/a n/a -83K n/a
    Operating Expenses
    		 28.81M 15.88M 11.42M 15.3M
    Interest Expense
    		 n/a n/a 2.19M n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 n/a 15.89M 11.42M 15.3M
    Income Tax Expense
    		 n/a n/a n/a -62K
    Shares Outstanding (Basic)
    		 77.57M 5.07M 321.7K 96.43K
    Shares Outstanding (Diluted)
    		 77.57M 5.07M 321.7K 96.43K
    EPS (Basic)
    		 -3.56 -2.46 -19.01 -157.85
    EPS (Diluted)
    		 -3.56 -2.46 -19.01 -157.85
    EBITDA
    		 -28.81M -12.46M -11.48M -15.24M
    EBIT
    		 n/a -12.47M -11.42M -15.28M
    Depreciation & Amortization
    		 n/a 7K 28K 48K

    Add to Watchlist